Iqirvo PBC denied for failing step therapy by Aetna?

Aetna's specific coverage criteria for iqirvo pbc are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Requires Step Therapy Before Approving Iqirvo for PBC

Step therapy (also called "fail-first") denials for Iqirvo in primary biliary cholangitis mean Aetna requires documentation that you have first tried one or more other therapies for PBC — and that those therapies were inadequate — before it will authorize Iqirvo. Step therapy protocols are common for specialty drugs, and for PBC in particular, there is an established therapeutic sequence that Aetna's policy likely mirrors.

This denial is very commonly reversed on appeal when complete documentation of prior treatment history is provided. The appeal strategy is straightforward: demonstrate that you have already completed the required steps, or document why you cannot safely do so.

## Your Federal Appeal Rights

• ERISA §503: Step therapy denials are fully appealable. Many states also have "step therapy override" laws that set explicit timelines and grounds for override (contraindication, prior failure, clinician determination of clinical appropriateness) — check whether your state has such a law, as it may give you additional rights.
• ACA §2719 external review: Available after exhausting internal appeals, generally within four months of the denial. Expedited review is available for urgent cases.
• Step therapy override request: File this concurrently with or prior to a formal appeal — it is often the faster path to approval.

## Concrete Appeal Steps

1. Obtain Aetna's written step therapy policy for PBC or for Iqirvo specifically — it will list exactly which drugs must be tried first and for how long. 2. Compile your complete prior therapy record (see documentation section below). 3. If you have already completed the required steps, the appeal is primarily a documentation exercise — submit the records and ask for reversal. 4. If you have not yet tried a required step drug, have your prescriber document why it is contraindicated, not appropriate, or not expected to be effective for your specific clinical situation. 5. Reference any applicable hepatology society guidelines (the relevant professional society such as AASLD) that support moving directly to Iqirvo in your clinical circumstances.

## Documentation to Gather

• Prior PBC therapy records: For each drug Aetna's step policy requires, provide the medication name, start date, end date, doses tried, reason for stopping (intolerance, insufficient response, contraindication per prescriber), and supporting lab or clinical documentation.
• Prescriber medical-necessity letter: Should address each step-therapy requirement directly — either confirming completion of the step or providing clinical rationale for bypassing it.
• Diagnosis and severity records: AMA serology, liver function trends, imaging, and specialist notes establishing the diagnosis and current disease status.
• Applicable guideline reference: Your prescriber should reference the relevant hepatology society's guidance on sequencing of PBC therapies to support the clinical rationale.
• State step therapy law (if applicable): If your state has a step therapy override statute, include a reference to it in your appeal letter.

## Criteria-Mapping Structure

List each step Aetna requires; document your status on each:

| Required Step Drug | Your Status (Tried / Contraindicated / Not Appropriate) | Supporting Evidence | |---|---|---| | [Drug name from Aetna policy] | [Status] | [Date, outcome, prescriber note] |

This table directly answers Aetna's requirement and leaves no ambiguity about your prior treatment history.